FindTrial
Sign In

Research for the Detection of Donor Derived Cell Free DNA (cfDNA) for the Early-stage Diagnosis of Acute Rejection Reaction Post Kidney Transplantation

Research for the Detection of Donor Derived Cell Free DNA (cfDNA) for the Early-stage Diagnosis of Acute Rejection Reaction Post Kidney Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019184
Enrollment
Unknown
Registered
2018-10-30
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Rejection Post-renal Transplantation

Interventions

Gold Standard:pathological puncture test and hematuria biomarker detection
Index test:dd-cfDNA

Sponsors

Shanghai Jiaotong University Renji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Control group: The allograft kidneys function normally. The rejection of allograft kidneys are excluded. The patients have no infectious complications. Case group: There is obvious evidence for acute rejection of the allograft kidneys. The patients have no infectious complications.

Exclusion criteria

Exclusion criteria: The patients have infectious complications. The patients have tumors. The patients are pregnant.

Design outcomes

Primary

MeasureTime frame
Donor derived cell free DNA;—

Countries

China

Contacts

Public ContactYuan Xiaodong

Shanghai Jiaotong University Renji Hospital

sduyuanxd@126.com+86 18516266816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026